Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Nov 2022	35	Global Markets Direct	ASDR-613178

Published: Nov 2022 - Pages : 35 - Publisher : Global Markets Direct - Report code : ASDR-613178

Astellas Pharma Inc
Bristol-Myers Squibb Co
Kiniksa Pharmaceuticals Ltd
Nekonal Sarl
Tonix Pharmaceuticals Holding Corp